Z. Du , X. Ge , Y. Li , Y. Qin , H. Fan , Y. Lv , X. Du , Y. Hu , Z. Liu
{"title":"30P:一线PD-1/PD-L1抑制剂治疗晚期非小细胞肺癌患者的临床特征和长期应答者的生存结局:一项多中心回顾性研究","authors":"Z. Du , X. Ge , Y. Li , Y. Qin , H. Fan , Y. Lv , X. Du , Y. Hu , Z. Liu","doi":"10.1016/S1556-0864(25)00225-4","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 3","pages":"Page S30"},"PeriodicalIF":21.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"30P: Clinical characteristics and survival outcomes of long-term responders for advanced non-small cell lung cancer patients with first-line PD-1/PD-L1 inhibitors: A multicenter retrospective study\",\"authors\":\"Z. Du , X. Ge , Y. Li , Y. Qin , H. Fan , Y. Lv , X. Du , Y. Hu , Z. Liu\",\"doi\":\"10.1016/S1556-0864(25)00225-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":17515,\"journal\":{\"name\":\"Journal of Thoracic Oncology\",\"volume\":\"20 3\",\"pages\":\"Page S30\"},\"PeriodicalIF\":21.0000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Thoracic Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1556086425002254\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Thoracic Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1556086425002254","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
30P: Clinical characteristics and survival outcomes of long-term responders for advanced non-small cell lung cancer patients with first-line PD-1/PD-L1 inhibitors: A multicenter retrospective study
期刊介绍:
Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer,is the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies.The readship includes epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, radiologists, pathologists, nuclear medicine physicians, and research scientists with a special interest in thoracic oncology.